Otolaryngology Doctors in Flemington, NJ Accepting Medicare

7 Otolaryngology doctors found. Showing 1 - 7

David F Kroon, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 6 Sand Hill Rd, Suite 302, Flemington, NJ 08822 Phone: 908-788-9131    Fax: 908-788-8094

Douglas L Worden, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 6 Sand Hill Rd, Suite 302, Flemington, NJ 08822 Phone: 908-788-9131    Fax: 908-788-0945

Stanley A Sheft, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 6 Sand Hill Rd, Suite 302, Flemington, NJ 08822 Phone: 908-788-9131    Fax: 908-788-0945

Dr. Shilpa Renukuntla, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 6 Sand Hill Rd Ste 302, Flemington, NJ 08822 Phone: 908-788-9131    Fax: 908-788-0945

Dr. John P Hanna, D.O. Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6 Sand Hill Rd, 302, Flemington, NJ 08822 Phone: 908-788-9131

Dr. Anoli Maniar, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 6 Sand Hill Rd, Suite 302, Flemington, NJ 08822 Phone: 908-788-9131    Fax: 908-788-0945

Stephen M Schwartz, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 6 Sand Hill Rd, Suite 302, Flemington, NJ 08822 Phone: 908-788-9131    Fax: 908-788-0945

News Archive

U.S. Department of Justice clears Aetna's proposed acquisition of Coventry Health Care

Aetna today announced the U.S. Department of Justice has cleared Aetna's proposed acquisition of Coventry Health Care, Inc. Aetna expects to complete its acquisition of Coventry within the next three business days.

Updated report analyzing approval rates at FDA published

Sagient Research Systems, a leading publisher of independent research for the financial services, institutional investment and corporate intelligence communities, recently published an updated report analyzing approval rates at the U.S Food and Drug Administration. According to its research service, BioMedTracker, the rate of drugs that were approved by the FDA in 2008 and 2009 has remained close to the historical low seen in 2007.

Benefits of new health insurance reform law for Medicare recipients discussed in news conference

Speaker Nancy Pelosi, Health and Human Services Secretary Kathleen Sebelius, House Majority Leader Steny Hoyer, Barbara Kennelly of the National Committee to Preserve Social Security and Medicare, and Dr. Ben Williamowsky of Silver Spring, Md., a Medicare recipient, held a news conference today to discuss benefits of and misconceptions about the Affordable Care Act and Medicare.

Endothelial tissue injury significantly contributes to ARDS in COVID-19 patients, finds study

A recent study conducted by scientists from the Yokohama City University, Japan, has revealed that elevated alveolar endothelial injury markers in coronavirus disease 2019 (COVID-19) patients with acute respiratory distress syndrome (ARDS) are the main causative factors for alveolar barrier disruption. In COVID-19 patients with ARDS, endothelial injury persists for a longer time than epithelial injury.

Women with bipolar disorder shoulder heavy medication burden

Study findings highlight the frequent use of complex polypharmacy in patients with bipolar disorder, with women especially likely to be taking multiple medications.

Read more Medical News

› Verified 2 days ago